What were the key financial performance indicators for EIDP, Inc. in 2024?

For the year ended December 31, 2024, EIDP, Inc. (as part of Corteva's consolidated results) reported net sales of $16.9 billion, a 2% decrease year-over-year. The Seed segment's net sales increased by 1% to $9.5 billion, while the Crop Protection segment's net sales decreased by 5% to $7.4 billion. R&D expenses increased to $1.4 billion.

What is the company's strategy for growth and innovation?

Corteva's strategy focuses on delivering top-tier technology in its core markets, achieving best-in-class cost performance, moving towards Seed royalty neutrality, improving product mix for differentiation, and driving operational improvements. The company is also focused on delivering innovation to farmers faster and deploys capital with discipline, prioritizing investment, growth opportunities, and returning cash to shareholders.

Are there any significant risks or challenges the company faces?

Key risks include regulatory hurdles for new products, evolving environmental and health regulations, climate change and unpredictable weather impacting agriculture, intense competition, supply chain disruptions due to geopolitical events, volatility in input costs, and potential litigation related to environmental matters and legacy EIDP businesses. Additionally, EIDP has identified a material weakness in its internal controls over financial reporting.

How is the company returning value to shareholders?

In 2024, the company returned approximately $1.5 billion to shareholders through share repurchases under its authorized programs and common stock dividends. The Board of Directors approved a 6.25% increase in the quarterly common stock dividend in July 2024.

CTA-PB/CTA-PA 10-K FY2024 Annual Report — Revenue, Net Income, EPS

Summary

EIDP, Inc. (CTA-PB) filed its 10-K for the period ending December 30, 2024, reporting net sales of $16.9 billion, a 2% decrease year-over-year. This decline was attributed to a 1% decrease in price and a 3% unfavorable currency impact, partially offset by a 2% increase in volume. The company's operations are divided into two segments: Seed and Crop Protection. The Seed segment saw a 1% increase in net sales to $9.5 billion, driven by a 3% price increase and 1% volume growth, though impacted by a 2% unfavorable currency effect. The Crop Protection segment experienced a 5% decrease in net sales to $7.4 billion, primarily due to a 5% price decline and a 3% unfavorable currency impact, partially offset by a 3% volume increase. The company continues to invest in innovation, with R&D expenses increasing to $1.4 billion. Strategic acquisitions in the biologicals space (Stoller and Symborg) are expected to complement the Crop Protection business. The company returned approximately $1.5 billion to shareholders through share repurchases and dividends in 2024.

Key Highlights

1Corteva's net sales for the year ended December 31, 2024, were $16.9 billion, a 2% decrease from the prior year, impacted by pricing and currency fluctuations.

2The Seed segment reported net sales of $9.5 billion, a slight increase driven by pricing and volume, with strong performance in key markets.

3The Crop Protection segment saw a 5% decline in net sales to $7.4 billion due to pricing pressures and unfavorable currency impacts, although volume saw a modest increase.

4Research and Development (R&D) expenses increased to $1.4 billion, reflecting continued investment in innovation and product pipeline development.

5The company returned approximately $1.5 billion to shareholders in 2024 through share repurchases and dividends, demonstrating a commitment to capital allocation.

6Corteva is focused on strategic priorities including executing its value creation framework, accelerating innovation delivery, and deploying capital with discipline.

7The company reported a material weakness in internal control over financial reporting for EIDP, Inc., related to the classification of intercompany cash flows with Corteva, Inc.

EIDP, Inc. Annual Report, Year Ended Dec 31, 2024

Summary

Key Highlights

Frequently Asked Questions